Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RAPIBLYK ® safely and effectively. See full prescribing information for RAPIBLYK. RAPIBLYK (landiolol) for injection, for intravenous use Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
RAPIBLYK is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter, and pediatric patients with supraventricular tachycardia.
- generic_name
- landiolol
- product_names
- landiolol
- ndc
- 84381-110, 84381-110-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en